Insider Selling: ASP Isotopes (NASDAQ:ASPI) Insider Sells $844,875.00 in Stock

ASP Isotopes Inc. (NASDAQ:ASPI) insider Paul Elliot Mann sold 112,500 shares of the company’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $7.51, for a total value of $844,875.00. Following the completion of the sale, the insider owned 7,971,691 shares in the company, valued at $59,867,399.41. This represents a 1.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Paul Elliot Mann also recently made the following trade(s):

• On Tuesday, November 25th, Paul Elliot Mann sold 50,000 shares of ASP Isotopes stock. The stock was sold at an average price of $5.77, for a total value of $288,500.00.
• On Monday, September 8th, Paul Elliot Mann sold 81,076 shares of ASP Isotopes stock. The shares were sold at an average price of $8.53, for a total transaction of $691,578.28.
• On Tuesday, September 9th, Paul Elliot Mann sold 81,077 shares of ASP Isotopes stock. The shares were sold at an average price of $8.39, for a total transaction of $680,236.03.

ASP Isotopes Price Performance

ASP Isotopes stock opened at $6.20 on Monday. The stock has a market capitalization of $687.10 million, a P/E ratio of -4.77 and a beta of 3.42. ASP Isotopes Inc. has a 12-month low of $3.65 and a 12-month high of $14.49. The company has a debt-to-equity ratio of 1.04, a current ratio of 6.14 and a quick ratio of 6.10. The firm’s 50-day moving average is $9.19 and its two-hundred day moving average is $8.82.

ASP Isotopes (NASDAQ:ASPI) last announced its quarterly earnings data on Wednesday, November 19th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.05). ASP Isotopes had a negative net margin of 1,259.12% and a negative return on equity of 190.44%. The firm had revenue of $4.89 million for the quarter, compared to analysts’ expectations of $2.25 million. Equities analysts predict that ASP Isotopes Inc. will post -0.24 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on ASPI. Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a report on Tuesday, November 25th. Loop Capital set a $15.00 target price on ASP Isotopes in a research report on Monday, October 27th. Finally, Canaccord Genuity Group reissued a “buy” rating and issued a $11.00 price target on shares of ASP Isotopes in a research note on Monday, November 24th. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $13.00.

Institutional Trading of ASP Isotopes

Several institutional investors have recently made changes to their positions in ASPI. Quantbot Technologies LP acquired a new position in ASP Isotopes in the third quarter valued at $34,000. Ameritas Investment Partners Inc. raised its holdings in shares of ASP Isotopes by 41.2% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company’s stock worth $40,000 after purchasing an additional 1,600 shares during the period. BNP Paribas Financial Markets lifted its stake in shares of ASP Isotopes by 84.9% in the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock valued at $41,000 after purchasing an additional 2,548 shares in the last quarter. Close Asset Management Ltd purchased a new stake in shares of ASP Isotopes during the 3rd quarter worth about $72,000. Finally, Tower Research Capital LLC TRC grew its holdings in shares of ASP Isotopes by 96.7% during the 2nd quarter. Tower Research Capital LLC TRC now owns 10,890 shares of the company’s stock worth $80,000 after purchasing an additional 5,353 shares during the period. 16.80% of the stock is owned by hedge funds and other institutional investors.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.